July 14, 2024

Anastomosis Devices Market to Reach US$ 21.2 Mn by 2022, Driven by Increasing Demand for Minimally Invasive Surgeries

Market Overview:

Anastomosis devices are used for the connection of blood vessels or other tubular structures during surgical procedures. These devices offer several advantages such as reduced surgical time, less post-operative complications, and improved patient outcomes. The growing demand for minimally invasive surgeries and the rising prevalence of cardiovascular diseases and cancer are driving the market growth. Additionally, advancements in technology and innovative product launches by key market players are further contributing to the market expansion.

Market Key Trends:

The key trend in the anastomosis devices market is the increasing adoption of robotic-assisted surgeries. Robotic surgical systems offer enhanced precision, dexterity, and control during complex surgical procedures, leading to improved surgical outcomes. These systems enable surgeons to perform highly precise and minimally invasive anastomosis procedures, resulting in reduced complications and faster patient recovery. Moreover, robotic-assisted surgeries provide better visualization and ergonomics, minimizing surgeon fatigue. The collaboration between surgical robotics companies and key market players in the anastomosis devices segment is expected to drive market growth in the coming years. With ongoing technological advancements and increasing acceptance of robotic-assisted surgeries, the demand for anastomosis devices is anticipated to witness significant growth in the future.
Segment Analysis:

The segment analysis of the anastomosis devices market reveals that the market can be segmented based on product type, application, and end-user. Among these segments, the dominating sub-segment is the vascular anastomosis devices. Vascular anastomosis devices are widely used in cardiovascular surgeries for creating connections between blood vessels. The increasing prevalence of cardiovascular diseases, along with the growing number of cardiovascular surgeries, plays a crucial role in the dominance of this sub-segment. Furthermore, the advancements in technology and the development of innovative products have also contributed to the growth of the vascular anastomosis devices segment. These devices offer several advantages, such as reduced procedure time, improved vascular anastomosis quality, and decreased post-operative complications, which further boosts their demand in the market.

Key Takeaways:

The Global Anastomosis Devices Market Demand  is expected to witness high growth, exhibiting a CAGR of 5.4% over the forecast period from 2023 to 2030. This growth can be attributed to the increasing prevalence of cardiovascular diseases and the growing number of cardiovascular surgeries worldwide. Additionally, the advancements in technology and the development of innovative anastomosis devices are expected to drive market growth.

In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the anastomosis devices market. This can be attributed to factors such as the increasing incidence of cardiovascular diseases, high healthcare expenditure, and the presence of well-established healthcare infrastructure in the region. Moreover, the rising geriatric population and the favorable reimbursement policies for cardiovascular surgeries in North America are expected to further propel market growth.

Key players operating in the anastomosis devices market include Medtronic, Liva Nova PLC, Dextera Surgical Inc., Ethicon US, LLC., Synovis Micro Alliance, Inc., Vitalitec International Inc., and MAQUET Holding B. V. & Co. KG., among others. These players focus on strategic collaborations, mergers and acquisitions, and new product launches to strengthen their market position and expand their product portfolio.


  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it